Navigation Links
Occlutech Clarifies Statement Regarding Favourable Opinion Obtained From AIPPI With Regard to Patents Held by AGA Medical
Date:4/17/2008

JENA, Germany, April 17 /PRNewswire/ -- Occlutech GmbH, the leading European manufacturer of cardiac occlusion devices today announced a clarification of a recent news release.

In a news release dated February 8th, 2008, Occlutech stated that it received an opinion from AIPPI the European "Association for the Protection of Intellectual Property" with regard to non infringement by Occlutech of certain European IP held by AGA Medical.

AIPPI has requested a clarification of this statement:

1) The name European International Association for the Protection of Intellectual Property was not stated correctly. The correct name is the "International Association for the Protection of Intellectual Property".

2) The opinion received by Occlutech which states that Occlutech is not infringing EP 0808138B1 and its Italian part 019020BE/2006 held by AGA Medical Corp was commissioned through the Italian National Group of AIPPI but not issued by AIPPI International itself. The opinion was issued by and in the name of three independent experts nominated by the Italian Group of AIPPI. The opinion was issued by the experts nominated by the Italian Branch of AIPPI and not by, in the name of or on behalf of AIPPI International or the Italian National Group of AIPPI.

The opinion was given without influence of Occlutech GmbH and the impartiality of the experts has subsequently been confirmed by the Italian Branch of AIPPI.

3) Such an independent opinion commissioned through AIPPI is an instrument aiming at giving the requiring party a qualified and impartial opinion. It does not represent an official opinion by AIPPI since AIPPI does not get involved in intellectual property disputes between parties on behalf or in favour of one of the parties.

Occlutech GmbH regrets that its communication was not clear with regard to the role of AIPPI in commissioning and receiving the opinion.

Occlutech GmbH develops and manufactures a wide ran
'/>"/>

SOURCE Occlutech GmbH
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. AGA Medical Corporation Responds to Occlutech Statement on the Status of the Ongoing Patent Litigation in Europe
2. Phlo Clarifies That Pre-Reverse Split Certificates Are Negotiable in Market Transactions
3. Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering
4. Oncothyreon announces effectiveness of shelf registration statement
5. WuXi PharmaTech (Cayman) Inc. Announces Filing of Registration Statement For Follow-On and Secondary Offering
6. Evotecs Registration Statement in Connection With its Proposed Acquisition of Renovis Declared Effective
7. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
8. Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006
9. Ortho Biotech Statement On JAMA Publication Regarding Erythropoiesis-Stimulating Agents
10. Cephalon Statement on Federal Trade Commission Action Regarding PROVIGIL Patent Settlements
11. APIC Statement on Need for Increased Prevention Measures for Healthcare-Associated Infections (HAIs)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... (PRWEB) November 25, 2014 Miles Holder, ... joined the Graphel Carbon Products team as Sales/Marketing Manager. ... marketing, and customer service for the graphite industry. , ... to our team,” stated Dave Trinkley, VP of Market ... wide range of experience in the graphite industry, along ...
(Date:11/26/2014)... TOKYO , 25 novembre 2014 Theravalues ... Super sur le marché européen au salon Hi ... Amsterdam ). Curcumine la ... une technologie amorphe (non-cristalline) à des ingrédients approuvés ... est un pigment jaune présent dans la racine ...
(Date:11/24/2014)... BUENA, N.J. , Nov. 24, 2014  IGI ... Jersey based specialty generic pharmaceutical company, today ... application (ANDA) to the U.S. Food and Drug Administration ... submissions in 2014 to seven, with eighteen submissions now ... Grenfell-Gardner , President and CEO of the Company, commented, ...
(Date:11/24/2014)... --   First published articles ... Elsevier , a world-leading provider of scientific, technical and ... launch of the latest title in the Current Opinion ... Science . Current Opinion ... platform to keep up-to-date with the expanding volume of information ...
Breaking Biology Technology:Miles Holder Joins Graphel Corporation as Sales/Marketing Manager 2La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 2La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 3IGI Laboratories, Inc. Announces ANDA Submission 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 3
... /Xinhua-PRNewswire-FirstCall/ -- China,Biologic Products, Inc. (OTC Bulletin ... of the leading plasma-based pharmaceutical companies in ... guidance following,the recently announced acquisitions which will ... of plasma based products in China., ...
... AMES, Iowa, Oct. 16 Advanced Analytical Technologies,Inc. (AATI), ... production space,adding an additional 1200 ft2 of space to ... company occupies in Building 4 on the,ISU Research Park ... company will continue to occupy space in 2 building ...
... Radiation Therapy Trials to US ... Patients for First Time, HOUSTON, Oct. 16 The ... they have entered into a,collaboration to increase patient access to ... setting., The collaboration means patients receiving cancer care at ...
Cached Biology Technology:China Biologic Products Provides Preliminary Guidance for 2009 of Revenues of $90 to $100 Million and Net Income of $18 to 22 Million 2China Biologic Products Provides Preliminary Guidance for 2009 of Revenues of $90 to $100 Million and Net Income of $18 to 22 Million 3Advanced Analytical Technologies, Inc. Expands Into New Office and Production Space 2Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials 2Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials 3Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials 4Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials 5
(Date:11/4/2014)... , Nov. 4, 2014   Neurotechnology ... today announced that the latest version of its ... the Ongoing MINEX evaluation organized by ... fingerprint algorithms using the INCITS 378 fingerprint standard ... requirement in public tenders in the ...
(Date:11/3/2014)... A University of Colorado Cancer Center study ... Academy of Sciences describes the activity of a ... Interleukin 37 or IL-37. It has been known to ... in the adaptive immune system: IL-37 inhibits the ability ... antigens. , "Knowing this mechanism that underlies IL-37,s effect ...
(Date:11/3/2014)... birth weight and preterm birth are linked to increased ... published in the American College of Rheumatology (ACR) journal, ... birth weight and pre-term babies were not at greater ... , According to the ACR, 27 million Americans ... OA. Symptoms of OA range from mild to severe ...
Breaking Biology News(10 mins):Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 3PNAS: From HIV to cancer, IL-37 regulates immune system 2Preterm, low birth-weight babies may need new hips in adulthood 2
... A University of Oklahoma-led study has demonstrated that ancient ... The microbiomes from ancient people have broad reaching implications ... what good bacteria might have been lost as a ... aseptic practices. Cecil M. Lewis Jr., professor of ...
... cell is like a small city, with factoriescalled organellesdedicated ... functions. A network of intercellular "highways," called microtubules, enables ... about the cell to keep this vital machinery humming. ... Proceedings of the National Academy of Sciences sheds ...
... researchers from across the Asia-Pacific gathered today for the ... Osteoporosis Meeting, taking place at the Kuala Lumpur Convention ... Minister of Health of Malaysia, YB Datuk Rosnah bt. ... than 60 nations. His Excellency Tun Dato, Seri Utama ...
Cached Biology News:OU study suggests the bacterial ecology that lives on humans has changed in the last 100 years 2Study sheds light on how cells transport materials along crowded intercellular 'highways' 2Study sheds light on how cells transport materials along crowded intercellular 'highways' 3IOF Asia-Pacific Meeting presents new research and advances in osteoporosis management 2IOF Asia-Pacific Meeting presents new research and advances in osteoporosis management 3
Required to perform reference file generation, flatfield calibration and performance verification processes on the GSD-501...
... Amplification Kit, 100 reactions. Prepare circular ... 4-6 h.Generate microgram quantities of template ... material.Use amplified DNA directly for cycle ... or M13 liquid cultures, colonies, plaques, ...
... Microplate Rack inserts fit ... Rack, and allow you to ... capacity, shake deepwell format plates ... many plates from the shaker ...
BD FastImmune EDTA Solution. Applications: Flow Cytometry Storage Temperature: Refrigerate(2 to 8C)...
Biology Products: